论文部分内容阅读
Background The aim of the study is to observe the influence of Calcium-channel blockers (CCBs) on the anti-platelet effect of clopidogrel and the incidence of major adverse cardiac and cerebral events (MACCE) on patients who accepted percutaneous coronary intervention (PCI).